|
October 14, 2005
IMMUNOLOGY: Special Delivery Brings
Fats to Immune System
Proteins access the immune system by well-known pathways of antigen presentation,
but work by Michael Brenner and colleagues reveals that fat-containing antigens,
including those from pathogens like the tuberculosis bacterium, take a different
and rather unexpected route. In a paper published in the Oct. 6 Nature, the
researchers show that the immune system coopts apolipoproteins, best known
as blood cholesterol carriers, to procure lipid antigens for presentation to
T cells. The convergence of two previously unrelated systems—the transfer
of dietary fats and cholesterol and the delivery of lipid antigens to the immune
system—has profound implications for the understanding of a host of diseases
from atherosclerosis to asthma.
|
|
NEUROLOGY:
Vaccine May
Clear Alzheimer’s
Brain Plaques
Many researchers believe that clearing the waxy amyloid plaques that fill the
brains of Alzheimer’s patients is the key to improving their cognitive
function. In the September Journal of Clinical Investigation, a team including
(from left) Dan Frenkel, Howard Weiner, and Ruth Maron unveils a novel vaccine
strategy for Alzheimer’s that clears the buildup of amyloid plaques in
a mouse model. The new strategy triggers cells of the immune system to gobble
up amyloid-beta. It is delivered as a simple nasal spray and consists of two
FDA-approved drugs already in use for other conditions.
|
|
PATHOLOGY:
Brain Injury Reversed in Animal Model of AIDS
Drugs that cannot breach the blood–brain barrier can reverse signs of AIDS-related
neurological damage in monkeys by suppressing infected immune cells in the blood
that continually assault the brain, report Kenneth Williams and colleagues in
the September Journal of Clinical Investigation. Born as monocytes in the blood,
the infected cells transform into dysfunctional macrophages in the brain at the
interface of blood vessels and nerves, where they presumably spew destructive
chemicals. The research may lead to strategies for treating the severe neurological
problems that affect about one third of people in this country who have AIDS.
|